The Ca²⁺/H⁺ antiporter TMEM165 expression, localization in the developing, lactating and involuting mammary gland parallels the secretory pathway Ca²⁺ ATPase (SPCA1)

详细信息    查看全文

• 作者：Timothy A. Reinhardt ; ^{tim.reinhardt@ars.usda.gov" class="auth_mail} ; John D. Lippolis ; Randy E. Sacco
• 关键词：Ca2+-ATPase ; TMEM165 ; Mammary calcium transport ; Mammary gland involution ; PMCA ; SPCA1 ; SPCA2
• 刊名：Biochemical and Biophysical Research Communications
• 出版年：7 March, 2014
• 年：2014
• 卷：445
• 期：2
• 页码：417-421
• 全文大小：1072 K

文摘

Plasma membrane Ca²⁺-ATPase 2 (PMCA2) knockout mice showed that 鈭?0% of calcium in milk is transported across the mammary cells apical membrane by PMCA2. The remaining milk calcium is thought to arrive via the secretory pathway through the actions of secretory pathway Ca²⁺-ATPase鈥檚 1 and/or 2 (SPCA1 and 2). However, another secretory pathway calcium transporter was recently described. The question becomes whether this Golgi Ca²⁺/H⁺ antiporter (TMEM165) is expressed sufficiently in the Golgi of lactating mammary tissue to be a relevant contributor to secretory pathway mammary calcium transport. TMEM165 shows marked expression on day one of lactation when compared to timepoints prepartum. At peak lactation TMEM165 expression was 25 times greater than that of early pregnancy. Forced cessation of lactation resulted in a rapid 鈭?0% decline in TMEM165 expression at 24 h of involution and TMEM165 expression declined 95% at 96 h involution. It is clear that the timing, magnitude of TMEM165 expression and its Golgi location supports a role for this Golgi Ca2⁺/H⁺ antiporter as a contributor to mammary Golgi calcium transport needs, in addition to the better-characterized roles of SPCA1&2.